133 related articles for article (PubMed ID: 4560302)
1. [Malignant lymphoreticular tumors neoplasms caused by immune disorders].
Cappelaere P
Lille Med; 1972 May; 17(5):738-48. PubMed ID: 4560302
[No Abstract] [Full Text] [Related]
2. [Significance of immunosuppression for the origin and growth of malignant tumors].
Reis HE
Dtsch Med Wochenschr; 1971 Jan; 96(4):170-4. PubMed ID: 4992740
[No Abstract] [Full Text] [Related]
3. Tumour development following immunosuppression.
Allison AC
Proc R Soc Med; 1970 Oct; 63(10):1077-80. PubMed ID: 4320709
[No Abstract] [Full Text] [Related]
4. Immunological disorders in the aetiology of lymphoreticular neoplasms.
Hoerni B; Laporte G
Rev Eur Etud Clin Biol; 1970 Oct; 15(8):841-50. PubMed ID: 4924913
[No Abstract] [Full Text] [Related]
5. Immunosuppressive chemotherapy and malignancy.
Schwartz RS
Transplant Proc; 1974 Dec; 6(4 Suppl 1):45-8. PubMed ID: 4612903
[No Abstract] [Full Text] [Related]
6. The role of immunosuppression in the genesis and growth of malignant tumours.
Reis HE
Ger Med Mon; 1971; 1(1):16-21. PubMed ID: 4931500
[No Abstract] [Full Text] [Related]
7. Effects of antilymphocyte serum on the induction of neoplasms of lymphoreticular tissues.
Law LW
Fed Proc; 1970; 29(1):171-4. PubMed ID: 4312738
[No Abstract] [Full Text] [Related]
8. [Pathogenesis of lymphoreticular neoplasms in transplant recipients].
Krüger G
Verh Dtsch Ges Pathol; 1970; 54():175-81. PubMed ID: 4104526
[No Abstract] [Full Text] [Related]
9. [Mechanism of induction of immunity to virus infections: interruption of intercellular virus multiplication].
Uetake H; Hamada C; Nakajima S
Tanpakushitsu Kakusan Koso; 1972 Nov; 17(11):835-47. PubMed ID: 4346822
[No Abstract] [Full Text] [Related]
10. [Chronic antigenic stimulation as a pathogenic factor in the development of malignant lymphoma].
Myking AO
Nord Med; 1971 May; 85(21):645-9. PubMed ID: 5581410
[No Abstract] [Full Text] [Related]
11. Malignant lymphoma. 1.
Aisenberg AC
N Engl J Med; 1973 Apr; 288(17):883-90. PubMed ID: 4348229
[No Abstract] [Full Text] [Related]
12. Cancer in the immunosuppressed patient.
Fahey JL
Ann Intern Med; 1971 Aug; 75(2):310-2. PubMed ID: 4934281
[No Abstract] [Full Text] [Related]
13. [Malignant neoplasms after organ transplantation].
Mol'kov IuN; Golikova SD; Balakirev EM
Vopr Onkol; 1980; 26(11):107-13. PubMed ID: 7006209
[No Abstract] [Full Text] [Related]
14. [Development of lymphoma and leukemia in patients receiving immunosuppressive drugs].
Rupniewska ZM; Kurowska M
Pol Tyg Lek; 1980 Mar; 35(11):411-4. PubMed ID: 6992123
[No Abstract] [Full Text] [Related]
15. The effects of antilymphocytic serum (ALS) on the development of lymphoma in mice. UCLA 12-724.
Vredevoe D; Hays EF
UCLA Rep; 1969 Jun; ():67-8. PubMed ID: 5372491
[No Abstract] [Full Text] [Related]
16. [Immunodeficiency and the development of malignant lymphoma].
Takahashi R
Rinsho Ketsueki; 1984 Sep; 25(9):1371-9. PubMed ID: 6394782
[No Abstract] [Full Text] [Related]
17. Immunosuppression and neoplasia.
Balner H
Rev Eur Etud Clin Biol; 1970; 15(6):599-604. PubMed ID: 4919177
[No Abstract] [Full Text] [Related]
18. Natural antitumor resistance in immune-deficient mice.
Stutman O
Exp Cell Biol; 1984; 52(1-2):30-9. PubMed ID: 6321257
[No Abstract] [Full Text] [Related]
19. Immunity and immunopathology in virus infections.
Allison AC
Ann Inst Pasteur (Paris); 1972 Oct; 123(4):585-608. PubMed ID: 4348598
[No Abstract] [Full Text] [Related]
20. Immunodepression and malignancy.
Stutman O
Adv Cancer Res; 1975; 22():261-422. PubMed ID: 766581
[No Abstract] [Full Text] [Related]
[Next] [New Search]
